• EPO-BM-MSCs Mitigate Asthma via HO-1–Driven Mitochondrial Tr

  2026-04-28

  Zhang et al. reveal that erythropoietin-modified bone marrow mesenchymal stem cells (EPO-BM-MSCs) alleviate airway inflammation in asthma by upregulating HO-1, which enhances mitochondrial transfer to injured epithelial cells via tunneling nanotubes. This mechanism provides a foundation for novel therapeutic strategies targeting intercellular organelle exchange in inflammatory lung diseases.

• Single-Nucleus RNA-Seq Reveals ATRNL1's Role in Atrial Fibri

  2026-04-28

  This study applies large-scale single-nucleus RNA sequencing to human atrial tissue, uncovering a crucial role for ATRNL1 in the pathogenesis of atrial fibrillation (AF). The findings provide new insight into cell type-specific gene regulation in AF, with implications for developing targeted therapies.

• Evaluating Low-Cost Microfluidic Mixers for LNP-mRNA Formula

  2026-04-27

  This study rigorously assesses whether low-cost microfluidic mixers can produce lipid nanoparticles (LNPs) suitable for mRNA delivery, comparing their performance to manual pipette mixing. Findings demonstrate that both microfluidic and manual approaches yield LNPs with high encapsulation and functional expression, supporting broader accessibility for small-scale and high-throughput research.

• WNT5a/GSK3/β-catenin Axis Modulates FAP Adipogenesis in Musc

  2026-04-27

  This study uncovers the WNT5a/GSK3/β-catenin signaling axis as a key regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological, single-cell, and transcriptomic approaches, the work demonstrates how modulating this pathway may counteract fat infiltration in muscle disease contexts.

• Probenecid: Applied Workflows and Troubleshooting in MDR and

  2026-04-26

  Probenecid (4-(dipropylsulfamoyl)benzoic acid) enables translational research by bridging multidrug resistance reversal and neuroprotection in complex cellular models. Learn how to optimize experimental workflows, troubleshoot common pitfalls, and leverage APExBIO's reliable supply for reproducible results.

• TRIM66 Regulates Monogenic Olfactory Receptor Expression in

  2026-04-25

  This study identifies TRIM66 as a pivotal epigenetic repressor ensuring that each olfactory sensory neuron expresses only a single olfactory receptor gene. The findings clarify a longstanding mechanistic gap in the regulation of monogenic expression, with broad implications for sensory neuroscience and epigenetic research.

• (-)-Arctigenin: A Precision MEK1 Inhibitor for Tumor Microen

  2026-04-24

  (-)-Arctigenin from APExBIO uniquely enables high-resolution modulation of MEK1 and NF-κB signaling in complex tumor microenvironment assays. Its low-nanomolar activity and robust anti-inflammatory, antiviral, and neuroprotective properties make it an advanced tool for dissecting cellular crosstalk and metastasis pathways.

• ZCL278 and Cdc42: Mechanistic Insights for Fibrosis & Neuron

  2026-04-24

  Explore ZCL278, a selective Cdc42 inhibitor, through a mechanistic lens connecting advanced fibrosis and neuronal assays. This article uniquely bridges molecular action with translational research, deepening your understanding of ZCL278's scientific utility.

• HOXC8 Suppresses Pyroptosis in NSCLC by Regulating Caspase-1

  2026-04-23

  This study demonstrates that HOXC8 transcriptionally represses caspase-1, preventing pyroptotic cell death and promoting lung tumorigenesis. The findings reveal a novel epigenetic mechanism by which HOXC8 recruits HDAC1/2 to the CASP1 promoter, highlighting a potential target for modulating cell death pathways in non-small cell lung carcinoma.

• Topotecan HCl: Mechanistic Insights and DNA Damage Precision

  2026-04-23

  Explore the advanced mechanisms of Topotecan HCl, a leading topoisomerase 1 inhibitor. This in-depth analysis reveals how precise DNA damage induction transforms oncology assays, with new guidance grounded in breakthrough neuroinflammation research.

• Chloroquine (SKU BA1002): Reliable Solutions for Cell Assays

  2026-04-22

  Chloroquine (SKU BA1002) stands out as a validated autophagy inhibitor and anti-inflammatory agent for malaria and rheumatoid arthritis research. This article delivers scenario-driven, evidence-based guidance to biomedical scientists, addressing real laboratory challenges and demonstrating how APExBIO’s Chloroquine ensures reproducibility, workflow efficiency, and robust data quality.

• Anlotinib hydrochloride (SKU C8688): Optimizing Angiogenesis

  2026-04-22

  This article equips biomedical researchers and lab technicians with scenario-driven solutions for angiogenesis and proliferation assays using Anlotinib hydrochloride (SKU C8688). Drawing on validated literature and product data, we demonstrate how this multi-target tyrosine kinase inhibitor delivers reproducibility, sensitivity, and workflow confidence for cell-based experiments.

• Dextromethorphan hydrobromide: Technical Guide for Neuroprot

  2026-04-21

  Dextromethorphan hydrobromide is a high-purity NMDA receptor antagonist intended for research on neuroprotection and excitotoxicity inhibition, particularly in in vitro and in vivo neuroscience workflows. It is not suitable for diagnostic or clinical use, and optimal performance depends on precise adherence to solubility, handling, and storage protocols.

• BRD4 Inhibition Enhances Erastin-Induced Ferroptosis via ROS

  2026-04-21

  This study demonstrates that pharmacological inhibition or genetic knockdown of BRD4 sensitizes diverse cell lines to erastin-induced ferroptosis by increasing reactive oxygen species and suppressing FSP1 expression. The findings highlight the mechanistic link between BRD4 activity, ferroptosis regulation, and potential anti-cancer strategies leveraging BET inhibitors.

• Foretinib (GSK1363089): Precision Multikinase Inhibition in

  2026-04-20

  Foretinib (GSK1363089) enables nanomolar-precision inhibition of tumor cell growth and metastasis, streamlining both in vitro and in vivo cancer research. This guide delivers practical protocols, troubleshooting insights, and evidence-driven optimization to maximize assay rigor and translational impact.

406 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page